Search the Newsreel

Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 519% Upside

RxSight Inc (NASDAQ:RXST) is scheduled to release its Q2 2026 earnings on August 7, 2026, with revenue expected at $32.55 million and earnings at $-0.32 per share. GuruFocus estimates a significant upside of 518.60% for RXST based on its GF Value of $38.91, despite …

Insight Enterprises Q2 Earnings Call Highlights

Insight Enterprises, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NSIT) 2026-08-07

This article first appeared on GuruFocus. Net Revenue: $2.4 billion, an increase of 15% in US dollar terms and 14% in constant currency. Gross Profit: Increased 18% year-over-year. Gross Margin: 21.7%, an increase of 60 basis points. Adjusted EBITDA: $190 million, up 29%, with …

Elsight Limited 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:ELSLF) 2026-08-06

Sight Sciences, Inc. Stock 12‑Month Price Target Raised to $8.6, Implies 55% Upside

The average 12-month price target for Sight Sciences, Inc. (SGHT) stock has been raised from $8.4 to $8.6 by 5 analysts, with a range of $6 to $12 per share. This new target suggests a potential upside of approximately 55% based on the August …

Sight Sciences Inc (SGHT) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and Raised ...

Sight Sciences Inc. (SGHT) reported strong Q2 2026 earnings, featuring a 20% year-over-year increase in total revenue to $23.4 million, marking its strongest quarterly growth in three years. The company also saw significant improvement in its interventional dry eye revenue, which nearly doubled, and …

UBS Group Forecasts Strong Price Appreciation for Sight Sciences (NASDAQ:SGHT) Stock

INSIGHT ENTERPRISES INC Q2 2026: Revenue $2.4B, EPS $2.57— 10-Q Summary

INSIGHT ENTERPRISES INC (NSIT) reported strong second-quarter 2026 results, with revenue reaching $2.4 billion and diluted EPS of $2.57. This growth was primarily driven by increased

Insight Enterprises (NSIT) Q1 2026 Earnings Call Transcript

Foresight Autonomous Holdings Ltd (FRSX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Foresight Autonomous Holdings Ltd (FRSX), noting that no earnings forecast score is currently available. It highlights an average price target of $4.00 based on 0 analyst ratings, indicating a strong buy with an 867.74% upside. The piece …

UBS Adjusts Price Target on Sight Sciences to $8 From $7, Maintains Buy Rating

UBS has increased its price target for Sight Sciences (SGHT) to $8 from $7, while reiterating a Buy rating on the stock. This adjustment follows Sight Sciences' Q2 2026 earnings call and news of FDA 510(k) clearance for its OMNI Ultra Surgical System. The …

Insight Enterprises (NSIT) Reports Q2 Earnings: What Key Metrics Have to Say

Insight Enterprises (NSIT) Q2 Earnings and Revenues Beat Estimates

Insight Enterprises (NSIT) came out with quarterly earnings of $3.86 per share, beating the Zacks Consensus Estimate of $2.95 per share. This compares to earnings of $2.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Earnings Flash (NSIT) Insight Enterprises, Inc. Reports Q2 Revenue $2.40B, vs. FactSet Est of $2.18B

Insight Enterprises, Inc. (NSIT) reported its Q2 revenue at $2.40 billion, exceeding the FactSet estimate of $2.18 billion. This announcement led to an increase in the company's shares. The company also reported Q2 adjusted EPS of $3.86 per share.

Insight Enterprises (NASDAQ:NSIT) Reports Bullish Q2 CY2026

Insight Enterprises (NASDAQ:NSIT) reported strong Q2 CY2026 results, surpassing Wall Street's revenue and adjusted EPS expectations with significant year-over-year growth. The IT solutions integrator saw a 14.7% increase in revenue and its non-GAAP profit was 31.8% above consensus estimates. Management also raised its full-year …

Insight Enterprises Q2 net sales rise 15% as earnings jump 65%

ODYS Q2'26 Earnings: EPS estimate is (0.29) USD

Odysight.ai Inc. (ODYS) is projected to release its Q2'26 earnings on August 6, with an estimated revenue of $580.00 thousand and an anticipated EPS of ($0.29). This report provides details on past and estimated revenue and EPS figures for the company.

RxSight Q2 Earnings Call Highlights

RxSight reported Q2 revenue of $33.7 million, with product sales down 19% year-over-year excluding collaboration revenue, due to competitive trialing and market headwinds. The new CEO, Aziz Mottiwala, has withdrawn full-year financial guidance to conduct a comprehensive assessment of the business and commercial strategy, …

Sight Sciences, Inc. Q2 2026: Revenue $23.39M, EPS $(0.08) — 10-Q Summary

Sight Sciences, Inc. (SGHT) reported strong second-quarter 2026 results, with revenue increasing to $23.39 million, a 19.5% year-over-year growth. The company also significantly reduced its net loss, improving diluted loss per share to $(0.08) from $(0.23) in the prior year. This financial improvement was …

New RxSight lenses are intended to reduce post-surgery office visits

RxSight, Inc. (NASDAQ: RXST) reported Q2 2026 revenue of $33.7 million, flat year-over-year, and a net loss of $12.1 million. The company announced a strategic collaboration with Alcon, appointed a new CEO, and introduced a next-generation Light Adjustable Technology platform with new lenses designed …

Insight Enterprises (NSIT) Earnings Date and Reports 2026 $NSIT

Insight Enterprises (NASDAQ:NSIT) Releases Earnings Results, Beats Expectations By $0.93 EPS

Insight Molecular Diagnostics Ord Shs (IMDX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Keysight Technologies (KEYS) Could Be 12% Undervalued On AI Infrastructure Momentum

Keysight Technologies (KEYS) is seeing strong momentum due to its role in AI infrastructure, with a 63.11% year-to-date share price return. While a "most followed narrative" suggests the stock is 12% undervalued at $336.96 against a fair value of $383.08, driven by AI demand …

Sight Sciences earnings beat by $0.07, revenue topped estimates

Is Insight Enterprises (NSIT) Quietly Redefining Its Margin Story With AI-Driven T&E Automation?

Insight Enterprises (NSIT) has partnered with Navan for AI-driven travel and expense management, aiming to improve efficiency and reallocate employee hours to higher-value work. This initiative supports Insight's strategy of shifting towards higher-margin, AI-enabled services and operational efficiency. The company's investment narrative projects significant …

Sight Sciences Sees Q2 Revenue Growth, Raises 2026 Guidance

Sight Sciences, Inc. reported strong financial results for Q2 2026, with revenue increasing by 20 percent to $23.4 million and a significant reduction in net loss. The company raised its full-year 2026 revenue guidance to $88 million to $92 million, driven by growth in …

Sight Sciences (NASDAQ:SGHT) Posts Earnings Results, Beats Estimates By $0.10 EPS

Earnings call transcript: Sight Sciences raises 2026 outlook on Q2 growth, shares fall

Sight Sciences reported a strong Q2 2026 with revenue increasing 20% year-over-year to $23.4 million, its fastest growth since 2023, and a narrowed net loss. The company raised its full-year 2026 revenue guidance to $88 million-$92 million and lowered adjusted operating expense guidance. Despite …

Sight Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary

Sight Sciences, Inc. has released its earnings summary for the quarter that ended on June 30. The report, provided by Refinitiv, gives an overview of the company's financial performance during this period.

RxSight Q2 FY26 net loss widens 2.6% to $12.1 million; revenue rises 0.3% to $33.7 million

RxSight reported a Q2 FY26 net loss of $12.1 million, a 2.6% increase, despite a 0.3% rise in revenue to $33.7 million. The revenue increase was primarily driven by a $6.5 million license fee, which offset a 19% decline in product sales. The company's …

Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) reported a Q2 loss of $0.08 per share, outperforming the Zacks Consensus Estimate of a $0.15 loss, and significantly improving from a $0.23 loss a year ago. The company also surpassed revenue estimates, posting $23.39 million against an anticipated $21.75 …

RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates

RxSight, Inc. (RXST) reported a narrower-than-expected Q2 loss of $0.11 per share, beating the Zacks Consensus Estimate of a $0.21 loss, and surpassed revenue estimates with $33.74 million. Despite beating estimates, the company's shares have fallen 40% year-to-date, while the broader S&P 500 gained …

Earnings call transcript: RxSight beats Q2 2026 estimates but withdraws guidance

RxSight reported better-than-expected Q2 2026 earnings and revenue, but its stock fell after the company withdrew its full-year guidance due to ongoing pressure in its core business. The ophthalmology company's adjusted EPS beat estimates by $0.25, and revenue topped forecasts, partly aided by a …

RxSight (RXST) Stock Falls on Q2 2026 Earnings

RxSight Inc (NASDAQ:RXST) is scheduled to release its Q2 2026 earnings on August 7, 2026, with revenue expected at $32.55 million and earnings at $-0.32 per share. GuruFocus estimates a significant upside of 518.60% for RXST based on its GF Value of $38.91, despite …

Keysight Technologies Inc. stock underperforms Wednesday when compared to competitors

Keysight Technologies Inc. (KEYS) stock fell by 1.53% on Wednesday, closing at $336.02. This decline occurred despite a mixed trading session where the Dow Jones Industrial Average rose, while the S&P 500 Index decreased. The stock's underperformance ended a four-day winning streak for the …